PATENT CLAIM ANALYSIS

Application Number: 15773807
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-11
Patent Classification: ["435", "456000"]

Abstract:
An improved method for preparing T cell populations expressing a chimeric antigen receptor is described.

Claim (Index 14):
The method of  claim 13  wherein the chimeric antigen receptor comprises: a transmembrane domain selected from: a CD4 transmembrane domain or variant thereof having 1-2 amino acid modifications, a CD8 transmembrane domain or variant thereof having 1-2 amino acid modifications, a CD28 transmembrane domain or a variant thereof having 1-2 amino acid modifications, and a CD3\u03b6 transmembrane domain or a variant thereof having 1-2 amino acid modifications; a costimulatory domain; and CD3\u03b6 signaling domain of a variant thereof having 1-2 amino acid modifications.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 93.0
- Lexical Diversity: 1.0
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15316792', '14375015', '14805193', '14830392', '14214728']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6532092139210356
- 35 USC 102 Novelty (BERT): 0.5361411395962222
- Combined Prediction Score: 0.6415024064885543
- Mean Citation Score: 365.591814
- Max Citation Score: 385.99188
- Similarity Product: 287.5929641526675

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test